PO

Przemek Obloj

CFO at bit.bio

United Kingdom

Overview 

Przemek Obloj is the CFO at bit.bio and an investor with a focus on health and climate. With a background including roles at top firms like CVC Capital Partners and McKinsey & Company, he has invested in companies like AgBiome at various stages, showcasing a strong track record in financial management and strategic investments.

Work Experience 

  • Chief Executive Officer

    2025 - Current

    bit.bio is a synthetic biology company creating and manufacturing human cells to enable biomedical research and cell therapy. It was spun out of the University of Cambridge in 2016 and has since raised over $200m from investors such as Arch Venture, Foresite Capital, Milky Way, Charles River Laboratories, National Resilience, Tencent, Verition Fund and Puhua Capital. bit.bio’s opti-ox™ precision cell programming and manufacturing technology enables conversion of induced pluripotent stem cells (iPSCs) into any desired human cell type. This can be achieved within days and at industrial scale, while maintaining exceptional purity and unparalleled consistency.

  • Investor

    2021

  • Chief Financial Officer

    2024 - 2025

  • Investment Advisory Board Member

    2020

  • Managing Partner & CIO

    2020 - 2023

  • Managing Director, Head of European Private Equity

    2016 - 2020

    Private Equity and Growth investing across Europe and the U.S.

  • Director

    2009 - 2016

  • Investor

    2007 - 2009

  • Analyst / Associate / Manager, Private Equity & Corporate Finance Practice

    2000 - 2007

McKinsey Growth Tech serves leading growth stage tech players, venture capital, and growth private equity

  • Analyst / Data Scientist

    1998 - 2000

    Provided data and analytical support to the Minister of Labour implementing a comprehensive pension reform in Poland, including a switch to a defined contribution scheme and introduction of pension funds

Articles About Przemek

Relevant Websites